Immunoblot analysis showed that SOX9 siRNA remarkably inhibited gemcitabine-dependent pCHEK1 in both CC-SW-1 and EGI-1 cells and MRP4 expression in CC-SW-1 cells (Fig. 4d–f). This evidence concerns the gene ABCC4 and cholangiocarcinoma.